Triplebar

Running Evolution at Hyper-Speed

Triplebar is a biotech company in Emeryville, United States, founded in 2019. It has raised $20.0M across 1 round.

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$20.0M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. to use credits for reveals, or explore the API.

About

Triplebar Bio, Inc. is a US-based biotechnology company that has developed a hyper-throughput biological screening platform combining droplet microfluidics and generative AI to rapidly discover breakthroughs for the world's most pressing challenges. Founded in 2019 by biochemist Dr. Jeremy Agresti, Triplebar analyzes billions of genetic variations daily to find optimal biological solutions at speeds and scales impossible with traditional methods. The platform runs evolution at hyper-speed, enabling development of novel enzymes, proteins, and bioproducts for applications including food and agriculture, sustainability, healthcare, and nutrition. In 2023, the company raised a $20M funding round.

Funding History

Data from Indexed.vcUpdated
Venture RoundFunding Round
$20.0M

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triplebar on Indexed.vc
<a href="https://indexed.vc/companies/triplebar"><img src="https://indexed.vc/api/badge/company/triplebar" alt="Triplebar on Indexed.vc" width="260" height="76" /></a>